WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma
Alexander Rialdi(Icahn School of Medicine at Mount Sinai), Arvin C. Dar(Memorial Sloan Kettering Cancer Center), Charles M. Rice(Rockefeller University), Mary E. Duffy(Tisch Hospital), Soo‐Yong Tan(Monash Health), Jordi Abril‐Fornaguera(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Alex P. Scopton(Tisch Hospital), Kevin Mohammed(Icahn School of Medicine at Mount Sinai), Denis Torre(Icahn School of Medicine at Mount Sinai), Ype P. de Jong(Beth Israel Deaconess Medical Center), Jian Jin(Icahn School of Medicine at Mount Sinai), Austin Meadows(Tisch Hospital), Elisa Arceci(Tisch Hospital), Ravisankar Rajarethinam(Agency for Science, Technology and Research), Radoslaw M. Sobota(Universitätsklinikum Aachen), Xufen Yu(Icahn School of Medicine at Mount Sinai), Pedro Molina-Sánchez(Icahn School of Medicine at Mount Sinai), Julia N. Zhao(Memorial Sloan Kettering Cancer Center), Josep M. Llovet(Icahn School of Medicine at Mount Sinai), Megan Schwarz(Icahn School of Medicine at Mount Sinai), Xuedi Wang(Icahn School of Medicine at Mount Sinai), Eleftherios Michailidis(Rockefeller University), Kyna Reyes(Icahn School of Medicine at Mount Sinai), Augusto Villanueva(NYU Langone Health), Manikandan Lakshmanan(Agency for Science, Technology and Research), Ivan Marazzi(Icahn School of Medicine at Mount Sinai), Ernesto Guccione(Tisch Hospital), Felix Rosemann(Icahn School of Medicine at Mount Sinai), Amaia Lujambio(Icahn School of Medicine at Mount Sinai), Yan Ting Lim(Agency for Science, Technology and Research), Slim Mzoughi(Icahn School of Medicine at Mount Sinai), Dan Hasson(Icahn School of Medicine at Mount Sinai), Z.M. Khan(Tisch Hospital), Frank Fonseca(Tisch Hospital), Marina Ruiz de Galarreta(Icahn School of Medicine at Mount Sinai)
Cited by 27
Related Papers
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k